Virtual reality assessment for asylum seekers with paranoid delusions
Paranoid Behaviour & Threat Evaluation in Asylumseekers Diagnosed With a Psychotic Disorder and Experiencing Paranoid Delusions: A Phenomenological Qualitative Virtual Reality Study
University Medical Center Groningen · NCT06692530
This study tests whether virtual reality can help understand the thoughts and feelings of asylum seekers with paranoid delusions to improve their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Medical Center Groningen (other) |
| Locations | 1 site (Balkbrug, Overijssel) |
| Trial ID | NCT06692530 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the behaviors and threat evaluations of asylum seekers experiencing paranoid delusions through the use of virtual reality (VR). By leveraging VR technology, researchers intend to assess thoughts, behaviors, and emotions in real-time, addressing the challenges posed by language and cultural differences in traditional diagnostic assessments. The study focuses on individuals aged 18 and over who are receiving treatment for psychotic disorders at CTP Veldzicht in the Netherlands. The goal is to evaluate the applicability of VR as a diagnostic tool for this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are asylum seekers aged 18 and over, diagnosed with paranoid delusions and receiving treatment at CTP Veldzicht.
Not a fit: Patients who are acutely psychotic or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance diagnostic accuracy and treatment approaches for asylum seekers experiencing paranoid delusions.
How similar studies have performed: While the use of VR in psychiatric assessments is emerging, this specific application for asylum seekers with paranoid delusions is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 or over * Receiving treatment from CTP Veldzicht * Seeking asylum in the Netherlands, registered with Centraal Opvang Asielzoekers (COA) * Classification (primary or subsidiary classification) of a disorder categorized within the 'schizophreniaspectrum- and other psychotic disorders' (DSM-V) * Diagnosed with the symptom of paranoid delusion, defined as a PANSS score on the delusion item (P6) \>2 Exclusion Criteria: * Unable to provide informed consent * Acutely psychotic, which means overwhelmed by psychotic symptoms, agitated, not able to participate in an interview, as judged by a therapist or socio-therapist.
Where this trial is running
Balkbrug, Overijssel
- CTP Veldzicht — Balkbrug, Overijssel, Netherlands (RECRUITING)
Study contacts
- Study coordinator: Ron Haarms, MSc
- Email: r.haarms@umcg.nl
- Phone: 650070910
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Schizophrenia Disorders, Paranoid Delusions